The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience.

Br J Neurosurg 2016 4;30(1):80-5. Epub 2015 Sep 4.

a Clinic of Haematology, Clinical Centre of Serbia , Belgrade , Serbia.

Background And Methods: The aim of the study was to evaluate retrospectively clinical course of 27 patients with primary central nervous system lymphoma (PCNSL) diagnosed and treated by different surgical approaches. Initial therapy-diagnostic approach included surgery with total tumour reduction (TTR) performed in 12 patients (44.4%), while partial reduction and biopsy were performed in 8 (29.7%) and 7 (25.9%) patients, respectively. All patients were treated with chemotherapy based on high-dose methotrexate (HD-MTX) with/without whole-brain radiotherapy (WBRT).

Results: The median overall survival (OS) and event-free survival were 37 and 31 months, respectively, with overall response rate of 74%. The patients who underwent an open surgery with TTR had significantly longer OS (median not reached), comparing with partial tumour reduction or biopsy only (Log-Rank χ(2) 6.08, p = 0.014) when median OS was 23 months. In patients with performance status according to Eastern Cooperative Oncology Group (ECOG PS) ≥ 3, OS was 23 months, contrary to ECOG PS 1-2 when median was not reached. The International Extranodal Lymphoma Study Group score (low, intermediate and high) also influenced OS between three risk groups (Log-Rank χ(2) 12.5, p = 0.002).

Conclusion: The treatment of PCNSL still remains doubtful, however possible benefit from the TTR followed with HD-MTX with/without WBRT should be reconsidered.

Download full-text PDF

Source
http://dx.doi.org/10.3109/02688697.2015.1071328DOI Listing
January 2017
35 Reads

Publication Analysis

Top Keywords

tumour reduction
8
central nervous
8
median reached
8
log-rank χ2
8
hd-mtx with/without
8
nervous system
8
total tumour
8
reduction biopsy
8
patients
6
open surgery
4
surgery ttr
4
rate 74%
4
underwent open
4
patients underwent
4
ttr longer
4
74% patients
4
performed 297%
4
χ2 608
4
608 0014
4
0014 median
4

References

(Supplied by CrossRef)

Abrey LE et al.
J Clin Oncol 2000

1993

Similar Publications